Medication info
Glymepiride Tablets 2mg (Glymepiride)

Glymepiride Tablets 2mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Green rectangular tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201902153 · Approved 2019.04.09 · Insurance code 670501550

Summary

Main use
Improvement of glycemic control in type 2 diabetes
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug treatment, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering medicines. When switching to this medicine from another oral glucose-lowering medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. Consider the efficacy and duration of action of the previously administered medicine. 4) Treatment monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodic adjustment of the insulin dose is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is administered with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It is administered as an adjunct when patients cannot control their blood sugar with diet and exercise alone and can be used as a monotherapy. If control is insufficient with oral hypoglycemics, it can be combined with insulin, and if not controlled with sulfonylureas or metformin monotherapy, it can be combined with metformin to enhance efficacy. This medication effectively helps improve blood sugar control in diabetic patients.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug treatment, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering medicines. When switching to this medicine from another oral glucose-lowering medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. Consider the efficacy and duration of action of the previously administered medicine. 4) Treatment monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management during treatment with a sulfonylurea. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Periodic adjustment of the insulin dose is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is administered with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication is not to be used in patients with insulin-dependent diabetes or in patients with diabetic ketoacidosis or in a comatose state. Additionally, those who have had an allergic reaction to this medication or sulfonylureas should not take it. There is no experience with this medication in patients with severely impaired liver or kidney function, and in such cases transitioning to insulin therapy is recommended. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. In patients with severe infections or those undergoing surgery or with severe trauma, insulin therapy is more appropriate. Patients with gastrointestinal disorders like diarrhea or vomiting should be cautious as food absorption may be inadequate, increasing the risk of hypoglycemia. This medication contains lactose, and individuals with certain genetic metabolic disorders should not take it. During the first week of dosing, the risk of hypoglycemia is increased, so blood sugar levels must be carefully monitored, especially in elderly patients, those with poor nutritional status or irregular eating habits, and those with impaired kidney or liver function. Those who frequently consume alcohol or take other medications simultaneously may also have an increased risk of hypoglycemia, so consult a physician. This medication contains Yellow No. 4 dye, and those allergic to this ingredient should use it cautiously. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, drowsiness, confusion, and in severe cases, loss of consciousness; if these symptoms occur, quickly consume sugar or inform a healthcare professional. Temporary blurred vision can occur, and gastrointestinal disorders, liver function abnormalities, and changes in blood cell counts have also been reported. Allergic reactions may include skin rashes, itching, and in severe cases, breathing difficulties or shock, so if symptoms appear, discontinue use immediately and consult a hospital. This medication must be combined with dietary therapy and exercise for blood sugar control, and regular intake is important. If hypoglycemia occurs, sugar should be quickly consumed, and artificial sweeteners will not be effective, so caution is needed. When receiving treatment at another hospital or pharmacy, be sure to inform them of this medication, and during stressful situations or surgeries, blood sugar management methods may change, so consult a physician. In the case of an overdose, hypoglycemia may lead to a comatose state, requiring immediate emergency treatment, and after use, proper storage away from children's reach is essential.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or activeness, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina pectoris, deep vein problems, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive skin reactions, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture, and it is safest to store at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Green rectangular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.